Abstract
Introduction
Congenital pulmonary airway malformation (CPAM) is a rare congenital abnormality that presents in 0.004% of all pregnancies, and constitutes <25% of all congenital pulmonary anomalies. 1 About 15%-50% of cases of congenital cystic lung disease are reported to be CPAM. 2 Congenital cystic adenomatoid malformation (CCAM) was first described by Ch'in and Tang in 1949 3 and is now also known as CPAM due to the new classification system established by Stocker et al. 4 There are five types of CPAM. 4 CPAM is a rare congenital lung lesion with an estimated incidence 1:25,000 to 1: 35,000 live births. The mortality rate is high with 12.5% death rate in newborn. 5 CPAM are not associated with race , age , maternal exposure to any given factor or genetic factor. 6 It occurs equally across races and gender. 7 Typically, it is diagnosed on prenatal ultrasound, 8 however, in the literature, it is also infrequentlv diagnosed in children and even less commonly in adults. 1 More than 90% of these cases have been reported to be diagnosed in the first two years of life. This malformation can spontaneously regress, increase in size or cause non-immune hydrops fetalis. 9 Its usual postnatal presentation is respiratory distress in the newborn period. This may be due to\pulmonary hypoplasia, mediastinal shift, spontaneous pneumothorax, and pleural effusions secondary to hydrops. Recurrent chest infections may be a feature later in life. 10 The most common presentation in adults is recurrent and resistant infections. However, some of these lesions are also found incidentally on chest imaging in asymptomatic patients. Other common presentations include pneumothorax, dyspnoea and haemoptysis. 1 Case Summary: A 6 month old baby girl was admitted to our paediatric ward of AWMC suffering from intermittent nonproductive cough for 15 days, high grade intermittent fever along with respiratory distress for 2 days in association with loose mucoid stool and occasional vomiting for same duration. She was born after an uneventful 37 weeks of gestation. Her birth body weight was 3500 gm. Prenatal ultrasonography and postnatal physical examination revealed no abnormalities. Mother did not give H/O previous hospitalization for any region after birth before this illness. She was the only issue of non consanguineous parents. Mother had no previous miscarriage or abortion and there was no family history of lung disease or malignancy. to a CPAM. The difference between the lesions is that arterial supply to CPAM is from the pulmonary artery whereas BPS has a systemic vascular supply. 12 The cause of CPAM is unknown. One theory holds that it is the result of bronchial structures failing to mature properly at the time the lungs begin to formthe fifth or sixth week of gestation. Another theory suggests that CPAM is due to an abnormal growth pattern of lung tissue that occurs as a result of bronchial obstruction. 4 Histologic studies reveal rapid vascular and epithelial growth within the tumor. Recent findings of accelerated cellular proliferation and decreased apoptosis within resected CPAM specimens further suggest a benign neoplastic development. 13 There is no known genetic cause for CPAM, and no cases of recurrence in a sibling or offspring have been reported. Increased cell proliferation and decreased apoptosis may cause malignant transformation. Pleuropulmonary blastoma and bronchioloalveolar carcinoma in particular have been reported. 4 Abnormal Hoxb-5 regulation causes specific alterations in airway branching. Normal lung tissue does not express significant levels of Hoxb-5 protein, while the adjacent CPAM with abnormal and immature airway express the high levels of Hoxb-5. The abnormal expression of this Hox gene could be associated with the development of aberrant branching patterns in BPS and CPAM . 14 In infants and children, malformations communicate with the tracheobronchial tree , creating a valvular mechanism , which causes hyperinflation of the cystic zone during inspiration and less deflation during expiration. Enlarged cysts compressing the normal pulmonary structure lead to the respiratory symptoms. Glandular tissue proliferation may cause mucin accumulation and recurrent infections. CPAM is now preferred over CCAM since the lesions are cystic in only 3 of the 5 types of these lesions and adenomatoid in only one type. 15 Classification system for CPAM Based on embryological level of origin and histological features by Stocker et al. 16 0. Incidence 1-3% . It is the rarest form and arises from trachea/bronchus. It involves the entire lungs. Cysts are small. Presentation is severe and lethal.
1. Commonest, representing 50-70% of all cases, arises from distal bronchus or proximal bronchiole. Respiratory distress and general condition improved gradually. A full course of antibiotic treatment was given. Then she was referred to thoracic surgeon for surgical resection. The baby underwent lobectomy and her postsurgical period was uneventful. After the surgery, baby is doing well for last 6 months without any major respiratory symptoms. Now she is developmentally age appropriate having normal growth. Presently, at the age of 1 year, her weight is 9.6 kg, length 75cm, W/H on 50th centile and L/A on 75th centile, OFC 45 cm that falls on 50th centile.
Discussion:
Congenital cystic lung disease in children is rare with various clinical presentations. Pulmonary sequestration, congenital pulmonary airway malformation (CPAM), congenital lobar emphysema, and bronchogenic cysts are the four major congenital cystic lesions found in the lungs. 11 .Broncho-pulmonary sequestration (BPS) is a condition which closely mimics CPAM but is lung tissue with no bronchial connection. The non functioning lung may also result in mass effect similar 17 However, our case was consistent with Type-2 CPAM that was associated with patent foramen ovale (PFO).
3. They account for 5-10 % of cases, arising from acinar type of tissue. They are composed of small cysts; hence the mass appears echogenic and solid on USG. The tissue is acinar with adenomatoid elements, arising from distal airways. Type 3 CPAM generally is unilateral .
4. They account for 5-15 % of cases and are alveolar in origin with unlined cysts. They contain large cysts that may be as large as 10 cm and may be associated with malignancy, especially pleuropulmonary blastoma. 16 Type 1, 2 and 4 usually involve only 1 lobe .Whole lung involvement can occur in type 0 and 3. 18 Our case was Type-2 CPAM and it was confined only in left lower lobe. The prenatal rate of detection of lung cysts at the routine 18-20th week scan is almost 100% and may be the most common example of actual presentation. Late pregnancy diagnosis of CPAM is less sensitive. Once a cystic lung lesion is detected on ultrasound, the location, volume, size, macrocystic or microcystic classification, and blood supply should be evaluated. 19 Serial prenatal sonographic examinations are important for helping to determine the prognosis and necessity for possible intrauterine treatment in patients with CPAM. The prognosis is highly variable and depends on the presence of fetal hydrops and fetal therapies such as needle aspiration, catheter shunt placement and fetal surgical resection can be applied. The majority of these lesions will regress or become normal echoic in late pregnancy. 20 Ebru et al reported a case of nonimmune hydrops fetalis associated with CPAM Type 2 diagnosed on 19 th weeks of gestation during antenatal USG. 21 But in this case mother was on regular antenatal check-up and USG was performed several times that did not reveal any abnormalities. Chitra et al. described steroids in selected cases may be an additional tool to delay or avoid fetal surgery by causing regression of the lesion. 22 Postnatal spontaneous resolution of CPAM rarely has been reported. 23 In some cases, the lesion appeared to shrink over time, while in others, the lesion spontaneously resolved. The cause of resolution of CPAM is not clear. John et al. described a case of type 4 CPAM who presented with spontaneous pneumothorax just after birth . Spontaneous resolution occurred , obviating the need for surgical intervention. 24 CPAM has been associated with the presence of rhabdomyosarcoma, pleuropulmonary blastema and most commonly bronchioalveolar carcinoma (BAC) and adenocarcinoma of the lung . 25 Type 1 CPAM may involve malignant transformation of mucinous bronchioalveolar carcinoma 26 and type 4 CPAM requires examination of the entire lesion to exclude pleuropulmonary blastoma. 4 I-Ching et al. described case of CPAM type 4 without any malignant transformation in a 1yr old girl presented with localized pneumothorax . 27 Suleyman et al. describe a threeday-old infant with respiratory distress and cystic lung lesion on her left lung. A lobectomy was performed at the age of three days, and the patient was diagnosed with congenital pulmonary airway malformation and adenocarcinoma in situ. 25 One published case report that identified a 6-year-old male with a type 1 CPAM and biopsy proven BAC. He was managed conservatively over a 15 year period and at age 21 he was diagnosed with metastatic adenocarcinoma. 28 The vast majority of authors recommend surgical excision of these lesions for definitive treatment, due to the risk of malignant transformation and recurrent pulmonary infection. This recommendation remains controversial, as some authors argue that the risk of malignant transformation is over stated. 29 Benjamin et al. described a patient who developed BAC at 19 years of age after resection. Therefore, it is recommended that patients with CPAM , even if resected should be followed closely for malignancy. 30 The treatment of asymptomatic CPAM is defined less clearly. Observation may be a choice, but the patient and/or his family should be informed about both the possibility of infection and the low but definite risk of malignancy. If resection is advised in asymptomatic cases, then most surgeons would schedule surgery between the neonatal period and the first birthday. The lung continues to grow and develop until at least two years of age, and there is some suggestion that there is better catch-up lung growth following early thoracotomy. 31 Limitation : Though we don , t have pathological proof of the lesion reported here , we believe that it most likely represent a type 2 CPAM on the basis of clinical presentations, USG and CT scan of the chest reports and child , s clinical well-being after surgery .
Conclusion:
CPAM is a rare pathology. Our case report documents a patient of 6 month old girl having pneumonia associated with CPAM Type 2 whose diagnosis was made incidentally. CPAM can present at any age and the clinical presentation vary from immediate postnatal respiratory failure to an accidental finding on chest radiography. Recurrent RTI and malignant transformation are the major concern of the undiagnosed patient. Surgical excision is recommended to make a definite diagnosis and rule out hidden malignancies. It is also the treatment of choice.
